Cavitwin Injection No. 1
L-Isoleucine 3.45g · L-Leucine 4.55g +20 more
Solution · Prescription medication · Combination
Daehan Pharmaceutical Co., Ltd.
MFDS item code 200301713 · Notified 2003.12.08 · Insurance code 645103111
Correction of deficiencies in fluids, electrolytes, and nutrition (amino acids and calories)
This medication is used to supply essential fluids, electrolytes, amino acids, and calories through intravenous nutrition for patients who cannot adequately receive nutrition orally or via the gastrointestinal tract.
Immediately before administration, open the partition and mix the entire contents of solutions A and B. ○Adults: The maximum daily dose is 1~1.5 g of total amino acids per kg of body weight. The infusion rate should not exceed 1.0 mL/kg per hour (equivalent to glucose 0.25 g/kg and amino acids 0.05 g/kg). Administration by infusion over 12~24 hours is preferred; this drug should generally be administered into a central vein. In older adults and patients with high protein requirements, such as patients with burns, adjust the dose and infusion rate appropriately.
In children, adjust the dose and infusion rate appropriately.
This medication must be used strictly according to the physician's instructions, and should not be administered simultaneously with calcium-containing intravenous preparations and ceftriaxone due to potential precipitation. It should not be used in patients with allergic reactions or specific electrolyte imbalances, renal and liver dysfunction, certain heart diseases, and infants under 2 years old. It should be administered with caution to patients with unstable health conditions such as bacteremia, liver failure, kidney failure, and heart failure, as there is a possibility of allergic reactions or asthma attacks due to sodium bisulfite. During administration, blood glucose, electrolytes, liver and kidney functions should be regularly monitored to detect adverse reactions early and respond appropriately. In case of overdose, symptoms such as acidosis, fluid overload, electrolyte imbalance, and hyperglycemia may occur, so the infusion rate and dosage must be strictly managed. The safety of this medication has not been established for pregnant or breastfeeding women, so it should only be administered if the therapeutic benefits outweigh the risks. Elderly patients may have reduced physiological functions, so caution is needed to administer it slowly and adjust the dosage accordingly. This medication should be administered slowly via central venous access, and peripheral venous injection should be avoided. Maintain aseptic conditions during administration, and do not use if there is discoloration of the solution, leakage, or damage to the packaging.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its effectiveness.
A pale yellow transparent liquid filled in a transparent plastic container that is divided internally by partitions.
1000mL
Even with the same ingredient, strength, dosage form and how it is taken can differ.
L-Isoleucine 3.45g · L-Leucine 4.55g +20 more
Solution · Prescription medication · Combination
Daehan Pharmaceutical Co., Ltd.
L-Isoleucine 1.475g · L-Leucine 1.925g +20 more
Solution · Prescription medication · Combination
Daehan Pharmaceutical Co., Ltd.
L-Isoleucine 1.48g · L-Leucine 1.93g +20 more
Solution · Prescription medication · Combination
Daehan Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.